Header Logo

Connection

SHELDON KAPLAN to Staphylococcal Infections

Back to Details
This is a "connection" page, showing publications SHELDON KAPLAN has written about Staphylococcal Infections.
SHELDON KAPLAN
Connection Strength
10.870
Staphylococcal Infections
  1. Infectious disease consultation in children with S. aureus Bacteremia: does it improve patient outcomes and quality of care? Pediatr Res. 2022 12; 92(6):1502-1503.
    View in: PubMed
    Score: 0.562
  2. Staphylococcus aureus Infections in Children: The Implications of Changing Trends. Pediatrics. 2016 04; 137(4).
    View in: PubMed
    Score: 0.356
  3. Clinical and Molecular Features of Decreased Chlorhexidine Susceptibility among Nosocomial Staphylococcus aureus Isolates at Texas Children's Hospital. Antimicrob Agents Chemother. 2016 Feb; 60(2):1121-8.
    View in: PubMed
    Score: 0.350
  4. Staphylococcus aureus retropharyngeal abscess in children. Pediatr Infect Dis J. 2015 Apr; 34(4):454-6.
    View in: PubMed
    Score: 0.334
  5. Community-associated Staphylococcus aureus infections in otherwise healthy infants less than 60 days old. Pediatr Infect Dis J. 2014 Jan; 33(1):98-100.
    View in: PubMed
    Score: 0.306
  6. Randomized trial of "bleach baths" plus routine hygienic measures vs. routine hygienic measures alone for prevention of recurrent infections. Clin Infect Dis. 2014 Mar; 58(5):679-82.
    View in: PubMed
    Score: 0.304
  7. Community-acquired staphylococcal musculoskeletal infection in infants and young children: necessity of contrast-enhanced MRI for the diagnosis of growth cartilage involvement. AJR Am J Roentgenol. 2012 Jan; 198(1):194-9.
    View in: PubMed
    Score: 0.266
  8. Acute hematogenous osteomyelitis in children: differences in clinical manifestations and management. Pediatr Infect Dis J. 2010 Dec; 29(12):1128-9.
    View in: PubMed
    Score: 0.247
  9. Clinical and molecular epidemiology of Staphylococcus aureus catheter-related bacteremia in children. Pediatr Infect Dis J. 2010 May; 29(5):410-4.
    View in: PubMed
    Score: 0.237
  10. Hospital-acquired Staphylococcus aureus infections at Texas Children's Hospital, 2001-2007. Infect Control Hosp Epidemiol. 2010 Feb; 31(2):183-90.
    View in: PubMed
    Score: 0.233
  11. USA300 is the predominant genotype causing Staphylococcus aureus septic arthritis in children. Pediatr Infect Dis J. 2009 Dec; 28(12):1076-80.
    View in: PubMed
    Score: 0.231
  12. Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005. J Clin Microbiol. 2009 Jun; 47(6):1628-30.
    View in: PubMed
    Score: 0.221
  13. Staphylococcus aureus: a community pathogen. Infect Dis Clin North Am. 2009 Mar; 23(1):35-52.
    View in: PubMed
    Score: 0.219
  14. Pediatric antibody response to community-acquired Staphylococcus aureus infection is directed to Panton-Valentine leukocidin. Clin Vaccine Immunol. 2009 Jan; 16(1):139-41.
    View in: PubMed
    Score: 0.214
  15. Commentary: Prevention of recurrent staphylococcal infections. Pediatr Infect Dis J. 2008 Oct; 27(10):935-7.
    View in: PubMed
    Score: 0.213
  16. Severe staphylococcal infections in children. Pediatr Ann. 2008 Oct; 37(10):686-93.
    View in: PubMed
    Score: 0.213
  17. Evaluation and treatment of community-acquired Staphylococcus aureus infections in term and late-preterm previously healthy neonates. Pediatrics. 2007 Nov; 120(5):937-45.
    View in: PubMed
    Score: 0.200
  18. Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2006 Oct 15; 43(8):953-60.
    View in: PubMed
    Score: 0.184
  19. Community-acquired methicillin-resistant Staphylococcus aureus infections in children. Semin Pediatr Infect Dis. 2006 Jul; 17(3):113-9.
    View in: PubMed
    Score: 0.182
  20. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics. 2006 May; 117(5):1673-9.
    View in: PubMed
    Score: 0.180
  21. Three-year surveillance of community onset health care-associated staphylococcus aureus infections in children. Pediatr Infect Dis J. 2006 Apr; 25(4):349-53.
    View in: PubMed
    Score: 0.179
  22. Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics. 2006 Feb; 117(2):433-40.
    View in: PubMed
    Score: 0.177
  23. Implications of methicillin-resistant Staphylococcus aureus as a community-acquired pathogen in pediatric patients. Infect Dis Clin North Am. 2005 Sep; 19(3):747-57.
    View in: PubMed
    Score: 0.172
  24. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis. 2005 Sep 01; 41(5):583-90.
    View in: PubMed
    Score: 0.171
  25. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis. 2005 Jun 15; 40(12):1785-91.
    View in: PubMed
    Score: 0.168
  26. Treatment of community-associated methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J. 2005 May; 24(5):457-8.
    View in: PubMed
    Score: 0.168
  27. Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics. 2005 Mar; 115(3):642-8.
    View in: PubMed
    Score: 0.166
  28. The Utilization of Echocardiography in Children With Staphylococcus aureus Bacteremia. J Pediatric Infect Dis Soc. 2024 Nov 04; 13(10):537-540.
    View in: PubMed
    Score: 0.162
  29. Penicillin susceptibility among Staphylococcus aureus skin and soft tissue infections at a children's hospital. Microbiol Spectr. 2024 Oct 03; 12(10):e0086924.
    View in: PubMed
    Score: 0.160
  30. Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J. 2003 Sep; 22(9 Suppl):S178-85.
    View in: PubMed
    Score: 0.149
  31. Predictive Factors to Guide Empiric Antimicrobial Therapy of Acute Hematogenous Osteomyelitis in Children. Pediatr Infect Dis J. 2023 06 01; 42(6):449-455.
    View in: PubMed
    Score: 0.144
  32. Going Back in Time: Increasing Penicillin Susceptibility among Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children. Antimicrob Agents Chemother. 2023 01 24; 67(1):e0119622.
    View in: PubMed
    Score: 0.143
  33. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J. 2002 Oct; 21(10):910-7.
    View in: PubMed
    Score: 0.140
  34. Reduced Ceftaroline Susceptibility among Invasive MRSA Infections in Children: a Clinical and Genomic Investigation. Antimicrob Agents Chemother. 2022 10 18; 66(10):e0074522.
    View in: PubMed
    Score: 0.140
  35. The Indirect Impact of the SARS-CoV-2 Pandemic on Invasive Group a Streptococcus, Streptococcus Pneumoniae and Staphylococcus Aureus Infections in Houston Area Children. Pediatr Infect Dis J. 2021 08 01; 40(8):e313-e316.
    View in: PubMed
    Score: 0.129
  36. Follow-up Blood Cultures in Children With Staphylococcus aureus Bacteremia. Pediatrics. 2020 12; 146(6).
    View in: PubMed
    Score: 0.124
  37. Cefazolin Inoculum Effect and Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children. Antimicrob Agents Chemother. 2020 08 20; 64(9).
    View in: PubMed
    Score: 0.121
  38. Clinical and Microbiologic Variables Predictive of Orthopedic Complications Following Staphylococcus aureus Acute Hematogenous Osteoarticular Infections in Children. Clin Infect Dis. 2019 11 13; 69(11):1955-1961.
    View in: PubMed
    Score: 0.115
  39. Comparison of Musculoskeletal Infections due to Nontyphoidal Salmonella Species and Staphylococcus aureus in Immunocompetent Children. Pediatr Infect Dis J. 2019 10; 38(10):1020-1024.
    View in: PubMed
    Score: 0.114
  40. Clinical Characteristics and Outcomes of Staphylococcus aureus Implant-associated Infections in Children. Pediatr Infect Dis J. 2019 08; 38(8):808-811.
    View in: PubMed
    Score: 0.113
  41. The prevalence of antiseptic tolerance genes among staphylococci and enterococci in a pediatric population. Infect Control Hosp Epidemiol. 2019 03; 40(3):333-340.
    View in: PubMed
    Score: 0.109
  42. Association of Vancomycin MIC and Molecular Characteristics with Clinical Outcomes in Methicillin-Susceptible Staphylococcus aureus Acute Hematogenous Osteoarticular Infections in Children. Antimicrob Agents Chemother. 2018 05; 62(5).
    View in: PubMed
    Score: 0.103
  43. Impact of Serum Vancomycin Trough Levels in the Treatment of Central Nervous System Shunt Infections Caused by Coagulase-Negative Staphylococci. Pediatr Neurosurg. 2018; 53(4):243-246.
    View in: PubMed
    Score: 0.103
  44. Analysis of Invasive Community-Acquired Methicillin-Susceptible Staphylococcus aureus Infections During a Period of Declining Community Acquired Methicillin-Resistant Staphylococcus aureus Infections at a Large Children's Hospital. Pediatr Infect Dis J. 2018 03; 37(3):235-241.
    View in: PubMed
    Score: 0.102
  45. Staphylococcus aureus Central Nervous System Infections in Children. Pediatr Infect Dis J. 2017 Oct; 36(10):947-951.
    View in: PubMed
    Score: 0.099
  46. The Influence of the Route of Antibiotic Administration, Methicillin Susceptibility, Vancomycin Duration and Serum Trough Concentration on Outcomes of Pediatric Staphylococcus aureus Bacteremic Osteoarticular Infection. Pediatr Infect Dis J. 2017 06; 36(6):572-577.
    View in: PubMed
    Score: 0.097
  47. Pediatric Prostatic Abscess Caused by Methicillin-susceptible Staphylococcus aureus. Pediatr Infect Dis J. 2017 04; 36(4):426-427.
    View in: PubMed
    Score: 0.096
  48. Healthcare-associated Staphylococcus aureus Bacteremia in Children: Evidence for Reverse Vancomycin Creep and Impact of Vancomycin Trough Values on Outcome. Pediatr Infect Dis J. 2016 Mar; 35(3):263-8.
    View in: PubMed
    Score: 0.089
  49. Susceptibility to local and systemic bacterial infections in intercellular adhesion molecule 1-deficient transgenic mice. J Infect Dis. 1995 Oct; 172(4):1001-6.
    View in: PubMed
    Score: 0.086
  50. Characterization of Staphylococcus aureus infections in children with Down syndrome. J Infect Chemother. 2015 Nov; 21(11):790-4.
    View in: PubMed
    Score: 0.086
  51. Staphylococcus aureus infections among children receiving a solid organ transplant: clinical features, epidemiology, and antimicrobial susceptibility. Transpl Infect Dis. 2015 Feb; 17(1):39-47.
    View in: PubMed
    Score: 0.082
  52. Molecular epidemiology of coagulase-negative Staphylococcus blood isolates from neonates with persistent bacteremia and children with central venous catheter infections. J Infect Dis. 1994 Jun; 169(6):1393-7.
    View in: PubMed
    Score: 0.079
  53. Staphylococcus aureus bacteremia without a localizing source in pediatric patients. Pediatr Infect Dis J. 2014 May; 33(5):e132-4.
    View in: PubMed
    Score: 0.078
  54. Use of intravenous rifampin in neonates with persistent staphylococcal bacteremia. Antimicrob Agents Chemother. 1993 Nov; 37(11):2401-6.
    View in: PubMed
    Score: 0.076
  55. Meningitis due to Staphylococcus aureus in children. Clin Infect Dis. 1993 Jun; 16(6):766-71.
    View in: PubMed
    Score: 0.073
  56. A conversation with Sheldon L. Kaplan, MD. Interview by Stanford T Shulman. Pediatr Ann. 2013 May; 42(5):216.
    View in: PubMed
    Score: 0.073
  57. Staphylococcus aureus infections in pediatric oncology patients: high rates of antimicrobial resistance, antiseptic tolerance and complications. Pediatr Infect Dis J. 2013 Feb; 32(2):124-8.
    View in: PubMed
    Score: 0.072
  58. Staphylococcus aureus infections in pediatric patients with diabetes mellitus. J Infect. 2012 Aug; 65(2):135-41.
    View in: PubMed
    Score: 0.068
  59. Staphylococcus aureus infections in HIV-positive children and adolescents. Pediatr Infect Dis J. 2012 Mar; 31(3):284-6.
    View in: PubMed
    Score: 0.067
  60. Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection. J Biol Chem. 2012 Mar 23; 287(13):9940-9951.
    View in: PubMed
    Score: 0.067
  61. Pathologic fractures in children with acute Staphylococcus aureus osteomyelitis. J Bone Joint Surg Am. 2012 Jan 04; 94(1):34-42.
    View in: PubMed
    Score: 0.067
  62. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011 Feb 01; 52(3):285-92.
    View in: PubMed
    Score: 0.063
  63. Needle aspiration for the etiologic diagnosis of children with cellulitis in the era of community-acquired methicillin-resistant Staphylococcus aureus. Clin Pediatr (Phila). 2011 Jun; 50(6):503-7.
    View in: PubMed
    Score: 0.062
  64. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011 Feb 01; 52(3):e18-55.
    View in: PubMed
    Score: 0.062
  65. Nasal Staphylococcus aureus colonization among mothers of term and late preterm previously healthy neonates with community-acquired Staphylococcus aureus infections. Pediatr Infect Dis J. 2011 Jan; 30(1):74-6.
    View in: PubMed
    Score: 0.062
  66. Staphylococcus aureus sinus infections in children. Int J Pediatr Otorhinolaryngol. 2011 Jan; 75(1):118-21.
    View in: PubMed
    Score: 0.062
  67. Optimal imaging strategy for community-acquired Staphylococcus aureus musculoskeletal infections in children. Pediatr Radiol. 2008 Aug; 38(8):841-7.
    View in: PubMed
    Score: 0.052
  68. Increase of the USA300 clone among community-acquired methicillin-susceptible Staphylococcus aureus causing invasive infections. Pediatr Infect Dis J. 2007 Dec; 26(12):1122-7.
    View in: PubMed
    Score: 0.050
  69. Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus. BMC Microbiol. 2007 Nov 06; 7:99.
    View in: PubMed
    Score: 0.050
  70. Outcome of heteroresistant Staphylococcus aureus infections in children. J Infect Dis. 1987 Jul; 156(1):205-8.
    View in: PubMed
    Score: 0.049
  71. Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics. 2006 Sep; 118(3):874-81.
    View in: PubMed
    Score: 0.046
  72. Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J. 2005 Mar; 24(3):201-6.
    View in: PubMed
    Score: 0.041
  73. Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J. 2004 Aug; 23(8):701-6.
    View in: PubMed
    Score: 0.040
  74. The changing face of pleural empyemas in children: epidemiology and management. Pediatrics. 2004 Jun; 113(6):1735-40.
    View in: PubMed
    Score: 0.039
  75. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J. 2003 Jul; 22(7):593-8.
    View in: PubMed
    Score: 0.037
  76. Clindamycin versus nafcillin or methicillin in the treatment of Staphylococcus aureus osteomyelitis in children. South Med J. 1982 Feb; 75(2):138-42.
    View in: PubMed
    Score: 0.033
  77. Impact of Health Care Exposure on Genotypic Antiseptic Tolerance in Staphylococcus aureus Infections in a Pediatric Population. Antimicrob Agents Chemother. 2017 07; 61(7).
    View in: PubMed
    Score: 0.024
  78. The Contemporary Microbiology and Rates of Concomitant Osteomyelitis in Acute Septic Arthritis. Pediatr Infect Dis J. 2017 03; 36(3):267-273.
    View in: PubMed
    Score: 0.024
  79. Primary deep venous septic thrombophlebitis in a child. J Pediatr. 1994 Mar; 124(3):439-41.
    View in: PubMed
    Score: 0.019
  80. Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother. 1993 Dec; 37(12):2522-6.
    View in: PubMed
    Score: 0.019
  81. Prospective evaluation of a shortened regimen of treatment for acute osteomyelitis and septic arthritis in children. J Pediatr Orthop. 2010 Dec; 30(8):942.
    View in: PubMed
    Score: 0.015
  82. Persistent bacteremia due to coagulase-negative staphylococci in low birth weight neonates. Pediatrics. 1989 Dec; 84(6):977-85.
    View in: PubMed
    Score: 0.014
  83. Computed tomography in bacterial meningitis of childhood. Pediatr Infect Dis J. 1988 Dec; 7(12):855-7.
    View in: PubMed
    Score: 0.013
  84. Vancomycin pharmacokinetics in premature infants. Pediatr Pharmacol (New York). 1985; 5(1):17-22.
    View in: PubMed
    Score: 0.010
  85. Ventricular fluid concentrations of vancomycin in children after intravenous and intraventricular administration. Pediatr Infect Dis J. 1990 Feb; 9(2):138-9.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.